UK Grapples with Severe Co-Codamol Shortage, Sparking NHS Crisis
The United Kingdom is confronting a severe and distressing shortage of the widely used painkiller co-codamol, with millions of patients affected and supplies not anticipated to return to normal until June 2026. Pharmacists across the nation are reporting that they are supporting distressed and distraught patients as the medication scarcity is set to persist well into the summer months, creating a significant public health concern.
Scale of the Shortage and Impact on Patients
Industry experts have revealed that more than 1.25 million doses of co-codamol are prescribed each month in the UK. The shortage is primarily impacting the 30mg/500mg tablet formulation, but it is also affecting other strengths, exacerbating the crisis. The National Pharmacy Association has been formally informed that supplies will remain disrupted until June, leaving a gap of at least four months where patients may struggle to access their usual medication.
NHS providers nationwide have highlighted the severity of the situation. For instance, NHS Grampian has explicitly stated there is a UK-wide shortage of co-codamol 30/500 tablets, warning patients that supplies will be limited from early February 2026 until the summer. The health board emphasised that alternative forms, such as capsules or soluble tablets, cannot fully meet demand, preventing a simple switch for patients.
Official Responses and Alternative Measures
In response to the crisis, the Department of Health and Social Care has added co-codamol to the list of medicines that cannot be hoarded or exported from the UK, aiming to mitigate the shortage. A notice issued this month confirms that some tablets will be in short supply from February to July 2026. Prescribers are being advised against starting new patients on the drug, and existing patients are being encouraged to transition to alternatives.
Patients are being offered several alternative options to manage their pain during this period:
- Using paracetamol on its own as a substitute.
- Implementing a plan to gradually reduce co-codamol intake.
- Replacing doses of co-codamol with paracetamol where feasible.
Paracetamol 500mg tablets are expected to remain available, providing a crucial fallback for those affected.
Pharmacy Struggles and Calls for Government Action
Olivier Picard, Chair of the National Pharmacy Association, has voiced deep concern over the situation. He stated that pharmacies are struggling to order supplies, with many reporting disruptions lasting until at least June. This is a distressing shortage, Picard remarked, noting that pharmacists are doing their utmost to help patients manage severe pain, often resorting to prescribing alternatives where possible.
Picard highlighted broader systemic issues, pointing out that medicine supply problems are compounded by the NHS not funding the full cost pharmacies incur to obtain medications. He called for urgent government action to address the growing list of medicine shortages impacting both patients and pharmacists. One proposed solution is to allow pharmacists to make simple, safe substitutions to prescriptions when an item is out of stock, thereby saving patients from having to return to their GP without medication.
The co-codamol shortage underscores a critical challenge within the UK's healthcare system, with patients left in distress and healthcare professionals scrambling to manage the fallout. As the crisis unfolds, all eyes are on government and NHS authorities to implement effective measures and ensure patient welfare during this difficult period.
